These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 25467221)

  • 1. The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.
    Jetly R; Heber A; Fraser G; Boisvert D
    Psychoneuroendocrinology; 2015 Jan; 51():585-8. PubMed ID: 25467221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder.
    Raskind MA; Thompson C; Petrie EC; Dobie DJ; Rein RJ; Hoff DJ; McFall ME; Peskind ER
    J Clin Psychiatry; 2002 Jul; 63(7):565-8. PubMed ID: 12143911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation.
    Cameron C; Watson D; Robinson J
    J Clin Psychopharmacol; 2014 Oct; 34(5):559-64. PubMed ID: 24987795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.
    Raskind MA; Peskind ER; Kanter ED; Petrie EC; Radant A; Thompson CE; Dobie DJ; Hoff D; Rein RJ; Straits-Tröster K; Thomas RG; McFall MM
    Am J Psychiatry; 2003 Feb; 160(2):371-3. PubMed ID: 12562588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder.
    Raskind MA; Peskind ER; Hoff DJ; Hart KL; Holmes HA; Warren D; Shofer J; O'Connell J; Taylor F; Gross C; Rohde K; McFall ME
    Biol Psychiatry; 2007 Apr; 61(8):928-34. PubMed ID: 17069768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating nightmares in posttraumatic stress disorder with dronabinol: study protocol of a multicenter randomized controlled study (THC PTSD-trial).
    Roepke S; Schoofs N; Priebe K; Wülfing F; Schmahl C; Röhle R; Zähringer J; Lotter T; Otte C; Koglin S
    BMC Psychiatry; 2023 May; 23(1):319. PubMed ID: 37147642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans.
    Raskind MA; Peskind ER; Chow B; Harris C; Davis-Karim A; Holmes HA; Hart KL; McFall M; Mellman TA; Reist C; Romesser J; Rosenheck R; Shih MC; Stein MB; Swift R; Gleason T; Lu Y; Huang GD
    N Engl J Med; 2018 Feb; 378(6):507-517. PubMed ID: 29414272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary findings concerning the use of prazosin for the treatment of posttraumatic nightmares in a refugee population.
    Boynton L; Bentley J; Strachan E; Barbato A; Raskind M
    J Psychiatr Pract; 2009 Nov; 15(6):454-9. PubMed ID: 19934720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD).
    Fraser GA
    CNS Neurosci Ther; 2009; 15(1):84-8. PubMed ID: 19228182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prazosin for treatment of nightmares related to posttraumatic stress disorder.
    Taylor HR; Freeman MK; Cates ME
    Am J Health Syst Pharm; 2008 Apr; 65(8):716-22. PubMed ID: 18387899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study.
    Taylor FB; Martin P; Thompson C; Williams J; Mellman TA; Gross C; Peskind ER; Raskind MA
    Biol Psychiatry; 2008 Mar; 63(6):629-32. PubMed ID: 17868655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Post-Traumatic Nightmares: a Review of Pharmacologic and Nonpharmacologic Treatments Since 2013.
    Waltman SH; Shearer D; Moore BA
    Curr Psychiatry Rep; 2018 Oct; 20(12):108. PubMed ID: 30306339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prazosin for military combat-related PTSD nightmares: a critical review.
    Writer BW; Meyer EG; Schillerstrom JE
    J Neuropsychiatry Clin Neurosci; 2014; 26(1):24-33. PubMed ID: 24515675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxazosin, an α-1-adrenergic-receptor Antagonist, for Nightmares in Patients with Posttraumatic Stress Disorder and/or Borderline Personality Disorder: a Chart Review.
    Roepke S; Danker-Hopfe H; Repantis D; Behnia B; Bernard F; Hansen ML; Otte C
    Pharmacopsychiatry; 2017 Jan; 50(1):26-31. PubMed ID: 27276365
    [No Abstract]   [Full Text] [Related]  

  • 15. The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder.
    Taylor F; Raskind MA
    J Clin Psychopharmacol; 2002 Feb; 22(1):82-5. PubMed ID: 11799347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.
    Feder A; Parides MK; Murrough JW; Perez AM; Morgan JE; Saxena S; Kirkwood K; Aan Het Rot M; Lapidus KA; Wan LB; Iosifescu D; Charney DS
    JAMA Psychiatry; 2014 Jun; 71(6):681-8. PubMed ID: 24740528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder.
    Cates ME; Bishop MH; Davis LL; Lowe JS; Woolley TW
    Ann Pharmacother; 2004 Sep; 38(9):1395-9. PubMed ID: 15252193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pilot, Randomized Clinical Trial of Bedtime Doses of Prazosin Versus Placebo in Suicidal Posttraumatic Stress Disorder Patients With Nightmares.
    McCall WV; Pillai A; Case D; McCloud L; Nolla T; Branch F; Youssef NA; Moraczewski J; Tauhidul L; Pandya CD; Rosenquist PB
    J Clin Psychopharmacol; 2018 Dec; 38(6):618-621. PubMed ID: 30335633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome.
    Yehuda R; Bierer LM; Pratchett LC; Lehrner A; Koch EC; Van Manen JA; Flory JD; Makotkine I; Hildebrandt T
    Psychoneuroendocrinology; 2015 Jan; 51():589-97. PubMed ID: 25212409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan.
    Raskind MA; Peterson K; Williams T; Hoff DJ; Hart K; Holmes H; Homas D; Hill J; Daniels C; Calohan J; Millard SP; Rohde K; O'Connell J; Pritzl D; Feiszli K; Petrie EC; Gross C; Mayer CL; Freed MC; Engel C; Peskind ER
    Am J Psychiatry; 2013 Sep; 170(9):1003-10. PubMed ID: 23846759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.